Excelsior Biopharma Inc. (TPEX:6496)

Excelsior Biopharma Statistics

Total Valuation

TPEX:6496 has a market cap or net worth of TWD 1.35 billion. The enterprise value is 1.64 billion.

Market Cap	1.35B
Enterprise Value	1.64B

Important Dates

The next estimated earnings date is Wednesday, February 11, 2026.

Earnings Date	Feb 11, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:6496 has 46.75 million shares outstanding. The number of shares has increased by 0.10% in one year.

Current Share Class	46.75M
Shares Outstanding	46.75M
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	31.88%
Owned by Institutions (%)	n/a
Float	16.87M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.57
PB Ratio	1.59
P/TBV Ratio	1.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.93
EV / Sales	1.91
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.33

Financial Position

The company has a current ratio of 3.02, with a Debt / Equity ratio of 0.43.

Current Ratio	3.02
Quick Ratio	1.26
Debt / Equity	0.43
Debt / EBITDA	n/a
Debt / FCF	-1.63
Interest Coverage	-19.87

Financial Efficiency

Return on equity (ROE) is -17.74% and return on invested capital (ROIC) is -13.60%.

Return on Equity (ROE)	-17.74%
Return on Assets (ROA)	-6.55%
Return on Invested Capital (ROIC)	-13.60%
Return on Capital Employed (ROCE)	-13.20%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.58
Inventory Turnover	1.82

Taxes

In the past 12 months, TPEX:6496 has paid 11.06 million in taxes.

Income Tax	11.06M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.43% in the last 52 weeks. The beta is -0.03, so TPEX:6496's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-9.43%
50-Day Moving Average	29.30
200-Day Moving Average	27.67
Relative Strength Index (RSI)	40.46
Average Volume (20 Days)	41,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:6496 had revenue of TWD 859.77 million and -165.68 million in losses. Loss per share was -3.59.

Revenue	859.77M
Gross Profit	349.18M
Operating Income	-154.26M
Pretax Income	-154.62M
Net Income	-165.68M
EBITDA	-136.61M
EBIT	-154.26M
Loss Per Share	-3.59

Balance Sheet

The company has 65.95 million in cash and 364.64 million in debt, with a net cash position of -298.68 million or -6.39 per share.

Cash & Cash Equivalents	65.95M
Total Debt	364.64M
Net Cash	-298.68M
Net Cash Per Share	-6.39
Equity (Book Value)	846.79M
Book Value Per Share	18.35
Working Capital	392.76M

Cash Flow

In the last 12 months, operating cash flow was -156.61 million and capital expenditures -67.68 million, giving a free cash flow of -224.29 million.

Operating Cash Flow	-156.61M
Capital Expenditures	-67.68M
Free Cash Flow	-224.29M
FCF Per Share	-4.80

Margins

Gross margin is 40.61%, with operating and profit margins of -17.94% and -19.27%.

Gross Margin	40.61%
Operating Margin	-17.94%
Pretax Margin	-17.98%
Profit Margin	-19.27%
EBITDA Margin	-15.89%
EBIT Margin	-17.94%
FCF Margin	n/a

Dividends & Yields

TPEX:6496 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.10%
Shareholder Yield	-0.10%
Earnings Yield	-12.31%
FCF Yield	-16.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:6496 has an Altman Z-Score of 2.29 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.29
Piotroski F-Score	2